Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01669473
Other study ID # 1U19HS021093-01
Secondary ID
Status Completed
Phase N/A
First received August 3, 2012
Last updated September 20, 2016
Start date June 2013
Est. completion date September 2016

Study information

Verified date September 2016
Source Northwestern University
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

This study seeks to evaluate a low-literacy strategy in a primary health care setting for promoting safe and effective prescription medication use among English and Spanish-speaking patients with diabetes.

The investigators hypothesize that in comparison with patients receiving standard care, the patients that received the Electronic Health Record (EHR) strategy will 1) demonstrate better understanding of how to safely dose out their medication regimen; 2) have fewer discrepancies in their medication lists; 3) take their medication regimen more efficiently; 4) have greater adherence to their medication regimen.


Description:

The strategy takes advantage of health information technology to assist patients with Medication Therapy Management (MTM) tasks, intervening with a set of low-literacy MTM printed tools triggered by the Electronic Health Record (EHR) in a primary health care clinic. Patients at the University of Illinois at Chicago (UIC) Medicine Clinic who are randomized to the intervention arm will be given three printed tools, one when they check in to the clinic and the other two when they check out. The Electronic Health Record (EHR) triggers the printing of these tools, and the receptionist hands them to the patient. Patients receive either English or Spanish language materials depending on the preference determined in the screening process and stored in their EHR.

Specific Aims

1. Refine and Field Test an EHR strategy for generating and distributing low literacy prescription information for English and Spanish-speaking patients

2. Assess the process of the EHR intervention and its fidelity for providing prescription information for patients at the point of prescribing and dispensing medications.

3. Evaluate the effectiveness of the EHR strategy to improve medication understanding, reconciliation, regimen consolidation, and adherence compared to standard care.

In addition, we will be powered to also investigate our strategy's impact on intermediary clinical outcomes including systolic blood pressure, HbA1c, and LDL cholesterol.


Recruitment information / eligibility

Status Completed
Enrollment 541
Est. completion date September 2016
Est. primary completion date August 2016
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria:

- 18-years old or older;

- have a diagnosis of diabetes mellitus either by ICD-billing codes or indicative medications;

- are prescribed at least (3) chronic condition medications according to the EHR medication list;

- are English or Spanish-speaking;

- have no imminent intention to move or change clinics within the next year;

- score 4 or higher on the six-question screener based on the Mini-Mental Status Exam;

- are primarily responsible for administering their own medications;

- prescribed a new chronic condition medication (including refills, and change in titrations) during their clinic visit and day.

Exclusion Criteria:

- under age of 18 years-old;

- does not speak English or Spanish;

- dependent on assistance for medication administration;

- scored less than 4 on the six-question screener;

- not prescribed a new medication or changed medication at clinical appointment;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research


Intervention

Other:
EHR Based Strategy to promote Safe and Appropriate Drug Use
The printed tools presented in the intervention include: Medication Review: a consolidated list of the medications a patient is currently taking. Medication Sheet: a medication information sheet, including simplified prescription instructions, for each medication that a patient is newly prescribed. Medication List: a table that lists all medications taken by the patient and provides an orientation on how to best organize and simplify their medication regimen

Locations

Country Name City State
United States Northwestern University Chicago Illinois
United States University of Illinois at Chicago Chicago Illinois

Sponsors (2)

Lead Sponsor Collaborator
Northwestern University University of Illinois at Chicago

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Medication adherence We will determine to what extent presenting low-literacy information about prescription medicines to patients with diabetes affects their adherence to a medication regimen compared to patients under standard care.
Adherence for each prescription medication will be measured through multiple methodologies.
One month after patients receive intervention materials No
Secondary Clinical outcomes-systolic blood pressure, HbA1, and LDL cholesterol. We will investigate our strategy's impact on intermediary clinical outcomes including systolic blood pressure for patients with hypertension, HbA1 for patients with diabetes, and LDL cholesterol for patients with hyperlipidemia, through chart extraction at pre and post-intervention. Baseline interview and after 6 months No
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT02261545 - The Effect of n-3 Fatty Acid Supplementation on Serum Levels, and Gene Expression of type2 Diabetes Patient Phase 4
Completed NCT02028091 - Diabetes Mellitus - A Diagnosis Trial by Means of Non Invasive Measurements N/A
Completed NCT01684813 - VERifynow in DIabetes Non-responsiveness: a Study on Switching From Clopidogrel to Prasugrel Phase 4
Completed NCT01252524 - Effect of Calcium Polycarbophil on Type II Diabetes Mellitus Control: a Randomized Double-blind Study N/A
Recruiting NCT01311401 - Predictors of Future Type 2 Diabetes Mellitus in Circassians Minority in Israel N/A
Completed NCT00563225 - 20 Week Bridging Study in Type II DM Phase 3
Recruiting NCT01565096 - Effect of Adding Vildagliptin on Beta Cell Function and Cardiovascular Risk Markers in Patients With Moderate Metabolic Control During Metformin Monotherapy Phase 4
Completed NCT00151697 - LANN-study: Lantus, Amaryl, Novorapid, Novomix Study Phase 3
Withdrawn NCT01453751 - Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered in Patients With Type II Diabetes N/A
Not yet recruiting NCT01775059 - Collection of Performance Data From the Integrated Sensor and Infusion Set. TRIAL 4 N/A
Completed NCT01281098 - Prospective, Randomized, Open Label, Phase II Study to Assess Efficacy and Safety of Macugen® (Pegaptanib 0.3 mg Intravitreal Injections) Plus Panretinal Photocoagulation and PRP (Monotherapy) in the Treatment With High Risk PDR. Phase 2
Completed NCT02036372 - Perioperative Insulin, GIK or GLP-1 Treatment in Diabetes Mellitus N/A
Completed NCT03258840 - EPA Supplementation on Vascular Inflammation, and Gene Expression of PON2 in Patients With Type II Diabetes Mellitus N/A
Active, not recruiting NCT01386801 - Multicenter Research Study to Build a Repository to Study Chronic Diseases in Indiana N/A
Completed NCT02144948 - Investigation of the Effect of E.-Coli-Nissle as Supporting Therapy to Standard Care of Diabetes Mellitus Type II Phase 3